|
40 |
[2020.07.02] CUBEBIO entering the living-area market by upgrading a life-friendly device, 'CMDD-04'
|
2020-07-02 |
15,956 |
|
39 |
[2020.06.30] CUBEBIO's subsidiary, FPA, have acquired ISO 13485:2016 for additional production facility.
|
2020-06-30 |
15,425 |
|
38 |
[2020.06.18] CUBEBIO Co., Ltd. develops 'Muti-Channel Automated Diagnostic Device' series for mass screening...Expansion of product lines for overseas export
|
2020-06-18 |
14,127 |
|
37 |
[2020.06.03] CUBEBIO signed a contract to incorporate FPA Co., Ltd., a company specializing in automated equipment development, into its subsidiary
|
2020-06-03 |
13,961 |
|
36 |
[2020.05.25] CUBEBIO, in vitro diagnostic company, awarded the Biotechnology Grand Prize
|
2020-05-25 |
15,885 |
|
35 |
[2020.03.19] CUBEBIO Obtains 'Export Permit' for Urine Diagnosis Medical Devices - 1100 square meters of mass production facility is under construction.
|
2020-03-19 |
18,545 |
|
34 |
[2020.02.28] CUBEBIO receives 'TI-3' rating for investment-type technology assessment, TCB (Technology Credit Bureau), recognized as 'excellent technology'
|
2020-03-09 |
14,321 |
|
33 |
[2020.02.04] CUBEBIO Participated in Arab Health 2020, the largest exhibition in the Middle East, and introduced Cancer Self-Diagnostic Device.
|
2020-02-04 |
16,971 |
|
32 |
[2019.10.18] CUBEBIO attends the World Cancer Leaders' Summit led by the Union for International Cancer Control (UICC)
|
2019-11-05 |
24,211 |
|
31 |
[2019.09.30] CUBEBIO is awarded the Global Top Technology Grand Prize at the World Class Small-Mighty Enterprise Award 2019 ceremony
|
2019-10-02 |
16,830 |
